Surmodics inc (SRDX)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10
Operating Activities:
Net income

6,630

6,430

7,592

2,285

-1,863

-1,591

-4,457

-2,304

1,098

70

3,926

6,103

9,317

9,632

9,985

8,765

8,756

10,986

11,947

12,934

12,607

12,015

12,031

13,373

12,906

14,549

15,167

14,221

14,152

11,773

10,231

-11,174

-10,394

-9,629

-18,506

0

0

0

Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Loss on sale of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,074

0

0

0

-

-

-

-

Depreciation and amortization

7,337

7,360

7,312

7,182

6,900

6,667

6,431

6,260

6,051

5,793

5,555

5,176

5,186

5,246

4,873

4,425

3,713

3,031

2,805

2,744

2,724

2,701

2,715

2,766

2,820

2,861

2,886

2,889

2,895

2,902

2,929

2,980

3,035

3,111

3,159

0

0

0

Stock-based compensation

5,584

5,239

5,077

5,019

4,994

5,135

4,807

4,149

3,804

3,586

3,472

3,735

3,616

3,949

3,844

3,269

3,069

2,540

2,381

2,135

2,086

3,049

3,337

3,612

3,776

2,973

2,552

2,465

2,376

2,170

2,671

3,048

3,270

3,703

3,650

0

0

0

Payment of contingent consideration obligations in excess of acquisition-date value

608

608

2,041

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of premium on held-to-maturity securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

31

52

72

86

93

0

0

0

Contingent consideration gain

-

-

-161

1,433

1,435

-478

675

-330

-1,065

554

-127

-344

817

1,820

1,492

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred taxes

513

-1,592

-1,088

-1,302

-3,191

-3,681

-2,277

-2,908

1,176

1,972

1,000

2,396

-1,138

250

261

-538

1,222

-179

93

196

607

278

-352

-624

-828

-124

-492

-146

-262

-644

-728

-1,602

-15

1,189

-1,283

0

0

0

Losses (gains) on strategic investments

-

-

7

7

7

7

177

0

0

0

-

-

-

-

-

-

-

-

492

503

551

154

842

805

778

937

1,430

0

0

0

-

-

-

-

-

-

-

-

Provision for bad debts

178

70

160

194

179

120

85

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefit from stock-based compensation plans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

432

220

1,336

1,379

236

227

-944

-1,163

-477

0

0

0

-

-

-

0

-

-

0

0

Unrealized foreign exchange (gain) loss

-

-

-

-

-

-

148

-273

-1,465

-1,317

-474

-235

593

354

-444

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,176

-19,624

-18,803

-18,795

-29,431

0

0

0

Other

-119

-39

-1

-15

57

-64

-45

0

0

0

-

-27

-6

-11

-13

0

0

0

-

0

0

0

-

-

-

-

-

-

-

0

-

0

0

0

-

0

0

0

Change in operating assets and liabilities:
Accounts receivable and contract asset

-1,040

-858

1,630

1,640

2,514

3,019

1,773

1,427

320

389

528

1,331

186

938

-911

-516

1,677

842

2,727

819

-683

-668

-581

440

699

694

263

-441

283

-351

685

-398

-1,376

-1,062

-1,873

0

0

0

Inventories

1,421

795

543

196

368

329

513

456

535

321

-97

-57

-86

-13

143

-373

-119

233

162

564

437

-3

-511

-310

-606

-390

-196

-53

-301

250

343

336

1,328

702

954

0

0

0

Prepaids and other

1,323

2,282

2,131

1,661

1,648

1,045

1,584

615

959

1,041

599

1,727

606

262

-409

-120

-395

-100

-141

-157

-62

119

23

-151

179

89

40

122

2

-174

-15

-28

-161

-137

-250

0

0

0

Accounts payable

-2,166

-426

-765

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

58

-1,562

-2,187

-927

205

3,581

5,086

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

1,835

1,312

2,351

3,710

987

1,421

-473

373

313

423

395

-738

195

-166

96

238

-94

-870

-1,290

-2,663

-1,554

-2,697

-2,997

570

0

0

0

Income taxes

-2,502

1,259

822

223

-357

-1,528

-842

-370

-1,193

49

-59

-1,735

2,359

-198

76

1,165

-1,409

-366

-309

455

-150

-418

116

-29

-226

-1,665

-989

-418

1,673

6,094

5,734

4,997

1,771

3,228

5,016

0

0

0

Deferred revenue

-2,015

-2,469

-3,512

-8,091

-8,052

18,217

20,651

22,746

24,417

-107

-124

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-51

0

0

0

Net cash provided by (used in) operating activities

13,233

12,534

8,038

348

2,683

28,033

34,052

35,619

37,221

12,716

14,053

14,255

19,849

20,839

25,166

21,557

17,816

15,814

15,066

18,147

19,431

19,817

18,537

18,343

16,892

16,624

17,781

17,545

18,277

21,092

17,626

17,695

14,935

18,119

22,900

0

0

0

Investing Activities:
Purchases of property and equipment

5,191

5,603

5,998

6,312

8,190

9,860

9,092

8,466

7,586

6,185

6,432

8,204

10,075

9,353

8,192

6,350

2,697

2,220

1,877

1,509

1,643

2,263

2,278

1,636

1,478

1,118

1,919

1,782

1,733

1,463

763

593

574

876

1,551

0

0

0

Purchases of available-for-sale securities

60,751

56,633

44,973

48,075

58,104

80,270

81,536

78,314

77,137

72,494

73,671

0

0

0

-

-

-

-

3,376

9,092

49,048

138,677

138,363

143,102

111,662

47,148

45,053

43,019

35,203

41,959

43,840

38,037

60,704

52,238

50,926

0

0

0

Cash proceeds from sales of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

42

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales and maturities of available-for-sale securities

51,425

48,883

61,458

66,828

76,409

73,551

71,951

75,881

69,800

75,200

63,871

0

0

0

-

-

-

-

22,199

26,902

73,335

160,779

162,673

168,336

111,387

46,915

44,853

42,840

34,982

41,720

43,556

37,740

60,338

51,805

50,364

0

0

0

Payments for acquisition, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25,859

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,650

0

0

0

Cash received from sale of strategic investment

-

-

7

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

709

658

631

1,659

2,236

0

0

0

-

-

-

-

-

-

-

-

Net cash (used in) provided by investing activities

-15,267

-14,093

9,754

11,954

5,128

-21,395

-23,500

-15,175

-14,699

-3,436

-16,189

-31,620

-45,558

-43,933

-55,468

-40,843

-8,687

468

16,694

16,205

22,328

19,522

22,387

24,096

-1,088

181

78

-432

-278

5,748

29,618

29,675

29,515

16,518

-11,604

0

0

0

Financing Activities:
Cash transferred to discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-45

-160

-386

-386

-354

-237

-43

-204

-116

-757

-610

3,192

27,665

19,361

19,241

17,687

-4,841

0

0

0

Issuance of common stock

777

778

723

979

1,976

1,970

2,089

1,615

633

586

444

426

457

497

494

543

587

605

710

615

531

566

512

494

515

396

419

337

360

349

344

0

0

0

-

-

-

-

Payments for taxes related to net share settlement of equity awards

2,383

1,991

2,688

2,889

6,103

6,088

4,557

4,384

1,161

1,157

2,156

2,145

2,149

2,164

388

386

450

453

825

807

738

739

1,111

0

0

0

-

-

-

-

236

0

0

0

-

-

-

-

Payment of contingent consideration obligations

2,592

2,592

9,064

0

0

0

-

-

-

-

-

-

-

-

305

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of deferred financing costs

-

-

-

-

-

-

-

-

-

-

96

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20,000

20,001

20,001

23,121

12,545

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefit from stock-based compensation plans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

432

220

20

-1

236

227

372

217

-477

0

0

0

-

-

-

0

-

-

0

0

Net cash used in financing activities

-5,198

-3,805

-11,029

-10,974

-13,191

-14,107

-3,393

-4,350

-6,154

-5,331

-6,510

-5,861

-1,789

-1,705

-199

-152

-178

-174

-19,683

-19,973

-20,188

-23,295

-12,908

-20,421

-27,897

-27,754

-17,904

-65,270

-57,646

-54,734

-54,921

61

242

425

530

0

0

0

Net cash (used in) provided by continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,077

14,379

21,571

16,044

28,016

22,018

-12,093

-10,949

-45

-48,157

-39,647

-27,894

-7,677

47,431

44,692

35,062

11,826

0

0

0

Effect of exchange rate changes on cash and cash equivalents

-30

-32

-70

-35

-212

-75

-25

179

435

344

193

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash and cash equivalents

-7,262

-5,396

6,693

1,293

-5,592

-7,544

7,134

16,273

16,803

4,293

-8,453

-23,306

-27,730

-25,015

-30,601

-19,452

8,974

16,108

12,077

14,379

21,571

16,044

28,016

22,018

-12,093

-10,949

-45

-48,157

-39,647

-27,894

-7,677

47,431

44,690

35,050

11,826

0

0

0

Cash and Cash Equivalents:
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-45

-160

-386

-386

-354

-237

-43

-204

-116

-119

27

905

-1,514

-2,288

-1,625

-3,842

-2,945

0

0

0

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29,817

29,801

29,066

25,545

-1,908

0

0

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

45

160

386

386

354

237

43

204

116

119

-28

-3,830

-28,303

-27,513

-27,443

-21,715

4,853

0

0

0

Net cash provided by discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

0

-1,027

-2

-12

0

0

0

0

Supplemental Information:
Cash paid for income taxes

49

194

193

176

282

905

914

1,118

1,015

1,229

2,114

4,286

6,105

7,565

6,710

6,172

6,015

6,521

6,510

6,086

5,875

6,202

6,295

6,718

6,571

7,011

7,115

6,928

5,977

2,265

2,060

389

1,960

-339

-398

0

0

0

Noncash transactions from investing and financing activities:
Acquisition of property and equipment, net of refundable credits in other current assets and liabilities

224

222

202

-153

368

592

632

962

135

69

109

29

254

223

50

42

-34

64

22

-100

84

-100

11

231

101

-60

26

564

458

754

553

8

-75

-236

104

0

0

0

Share repurchase accrual

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of performance shares, restricted and deferred stock units

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,390

1,327

1,260

2,250

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Strategic investment gain receivable included in other current assets

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash transactions - issuance of shares associated with long-term incentive plan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Noncash transactions - issuance of performance shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Noncash transaction - acquisition of intangibles on account

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0